Epigenetic Age (DNAm): Which Tests to Order Alongside

What Epigenetic Age (DNAm) Actually Measures

Epigenetic age testing analyzes DNA methylation patterns at specific cytosine-guanine dinucleotide (CpG) sites across your genome. The result is a biological age estimate that may differ from your chronological age by years or even decades. Steve Horvath's original 2013 clock used 353 CpG sites and correlated with chronological age at r = 0.96 across 51 tissue types [1].

Since then, second-generation clocks have shifted from estimating chronological age to predicting clinical outcomes. GrimAge, developed by Lu et al. in 2019, incorporates DNA methylation surrogates for seven plasma proteins and smoking pack-years [2]. In a meta-analysis of 6,935 participants from the Framingham Heart Study and the Women's Health Initiative, each 5-year increment of GrimAge acceleration was associated with a 56% increase in all-cause mortality (HR 1.56 to 95% CI 1.42 to 1.71) [2]. That makes GrimAge the single most predictive epigenetic clock for mortality available today.

The clinical value of these clocks is real. But a methylation readout alone cannot explain why someone is aging faster. That requires companion labs.

Why a Single Epigenetic Clock Is Not Enough

A DNAm age result tells you the "what" but not the "how." Two patients with identical GrimAge acceleration of +7 years may have entirely different drivers. One might show chronic low-grade inflammation. The other might have severe insulin resistance with normal inflammatory markers. Without paired testing, the clinician has a number but no therapeutic lever to pull.

Dr. Morgan Levine, who developed the PhenoAge clock, has stated: "Epigenetic clocks are best used as part of a panel, not in isolation. The methylation signal integrates many upstream exposures, and disentangling those exposures requires complementary biomarkers" [3].

This is the core rationale for building a paired-test protocol. The epigenetic age result becomes actionable only when you can identify which biological systems are contributing to accelerated aging.

Inflammatory Markers: hsCRP, IL-6, and TNF-alpha

Chronic low-grade inflammation, sometimes called inflammaging, is one of the strongest drivers of epigenetic age acceleration. Start here.

High-sensitivity C-reactive protein (hsCRP) is the most accessible inflammatory marker. The American Heart Association defines cardiovascular risk categories as low (<1.0 mg/L), moderate (1.0 to 3.0 mg/L), and high (>3.0 mg/L) [4]. In the InCHIANTI cohort (N=1,016, age 21 to 102), participants in the highest quartile of IL-6 showed 2.2 years of epigenetic age acceleration compared to the lowest quartile on the Horvath clock [5].

Order hsCRP as the minimum. If the budget allows, add interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) for a more complete inflammatory profile. IL-6 is the upstream cytokine that drives hepatic CRP production, so it can flag inflammation before CRP rises. TNF-alpha adds specificity for adipose-tissue-driven inflammation, which matters in patients on GLP-1 receptor agonists or in metabolic syndrome.

A patient whose epigenetic age is +8 years with an hsCRP of 4.2 mg/L has a clear first target. Reduce inflammation through lifestyle, pharmacotherapy, or both, and retest in 6 months.

Metabolic Panel: Fasting Insulin, HbA1c, and Lipid Profile

Metabolic dysfunction accelerates biological aging through multiple pathways: glycation of proteins, oxidative stress, mitochondrial dysfunction, and epigenetic drift. The minimum metabolic panel to pair with DNAm age includes fasting insulin, HbA1c, and a standard lipid panel.

Fasting insulin is the earliest metabolic alarm. It rises years before fasting glucose leaves the normal range. The AACE recommends screening for insulin resistance in patients with metabolic risk factors, and a fasting insulin above 10 to 12 µIU/mL raises concern even when glucose is normal [6]. In a 2022 analysis of 2,764 participants in the Framingham Offspring cohort, each standard-deviation increase in HOMA-IR was associated with 1.6 years of GrimAge acceleration (P <0.001) [7].

HbA1c captures 90-day glycemic exposure. The ADA diagnostic thresholds are well-established: normal (<5.7%), prediabetes (5.7% to 6.4%), and diabetes (≥6.5%) [8]. Even within the "normal" range, an HbA1c of 5.5% vs. 5.0% may reflect meaningful metabolic differences in a longevity context.

Add a standard lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides) and, when possible, an advanced lipid panel with ApoB and Lp(a). ApoB provides a single-number summary of atherogenic particle burden and correlates with cardiovascular aging. Lp(a), which is 80% to 90% genetically determined, identifies patients whose vascular aging risk will not respond to lifestyle alone [9].

Hormone Assays: DHEA-S, IGF-1, and Sex Hormones

Hormonal decline is a hallmark of aging, and several hormones correlate directly with epigenetic clock outcomes. DHEA-S, the most abundant circulating steroid hormone, declines roughly 2% to 3% per year after age 30 [10]. In the Baltimore Longitudinal Study of Aging, lower DHEA-S levels predicted faster epigenetic age acceleration, particularly in men over 60 [11].

IGF-1 occupies a more complex position. Both very high and very low IGF-1 levels associate with mortality in a U-shaped curve. The European Journal of Endocrinology published data from 12,495 participants showing that IGF-1 concentrations in the lowest and highest quintiles carried 1.3-fold and 1.2-fold mortality risk, respectively, compared to the middle quintile [12]. For clinical purposes, an IGF-1 in the mid-normal range for age is the target.

Sex hormones round out this panel. For men, order total testosterone, free testosterone (by equilibrium dialysis when available), and SHBG. The Endocrine Society guideline defines male hypogonadism as a total testosterone below 300 ng/dL on two morning samples [13]. For women, particularly those in perimenopause or postmenopause, order estradiol, progesterone (if cycling), FSH, and SHBG. Declining estradiol in menopause accelerates epigenetic aging: a study of 3,100 women in the Women's Health Initiative showed that each year of earlier menopause was associated with 0.4 years of additional Horvath age acceleration [14].

Telomere Length: A Complementary but Distinct Marker

Telomere length and epigenetic age measure different aspects of biological aging. Telomeres shorten with each cell division and reflect replicative aging. Epigenetic clocks capture methylation changes across tissues and reflect cumulative environmental exposures. The correlation between the two is modest (r = -0.1 to -0.3 in most studies), which means they provide non-redundant information [15].

Order telomere length alongside DNAm age if you want a second biological age axis. Short telomeres (below the 10th percentile for age) have been associated with increased risk of cardiovascular disease, type 2 diabetes, and certain cancers in the NHANES dataset [16]. A patient with accelerated epigenetic age but normal telomere length for age may be experiencing environmental or metabolic aging drivers rather than replicative senescence.

The practical limitation: telomere length testing has higher measurement variability than epigenetic clocks. qPCR-based assays (the most common commercial method) have coefficients of variation of 5% to 10%, while Southern blot (TRF) remains the gold standard but costs more [16].

Complete Blood Count with Differential

A CBC with differential is inexpensive, universally available, and surprisingly informative in an aging context. The neutrophil-to-lymphocyte ratio (NLR) has emerged as a simple proxy for systemic inflammation and immune aging. An NLR above 3.0 in a non-acutely-ill adult correlates with elevated inflammatory burden [17].

Red cell distribution width (RDW) is another CBC parameter with aging relevance. In a 2020 meta-analysis of 22 studies and over 4 million participants, elevated RDW was associated with a 71% increase in all-cause mortality (HR 1.71 to 95% CI 1.57 to 1.86) [18]. RDW reflects heterogeneity in red blood cell size, which may signal nutritional deficiencies (iron, B12, folate), chronic inflammation, or bone marrow dysfunction.

White blood cell count itself is a crude aging marker. The Dunedin Study (N=954, followed from birth to age 45) found that higher WBC count at age 38 correlated with faster pace of biological aging measured by DunedinPACE, a newer methylation-based velocity-of-aging metric [19].

Order a CBC with differential as part of every longevity panel. The cost is negligible, and the data it adds is substantial.

Oxidative Stress and Nutrient Status

Oxidative stress drives DNA damage and epigenetic drift. Measuring it directly in clinical practice remains challenging, but several accessible proxies exist.

Homocysteine is both a cardiovascular risk marker and a methylation indicator. Elevated homocysteine (above 12 µmol/L) may signal inadequate B-vitamin status, specifically folate, B12, and B6, which are direct methyl donors [20]. Since DNA methylation is the very substrate that epigenetic clocks measure, compromised methylation capacity from B-vitamin insufficiency could contribute to clock acceleration. The AACE recommends checking homocysteine in patients with cardiovascular risk factors [6].

Order homocysteine, serum B12, folate, and 25-hydroxyvitamin D. Vitamin D merits inclusion because the VITAL trial (N=25,871) and subsequent analyses have linked vitamin D sufficiency (25(OH)D ≥30 ng/mL) with reduced inflammatory markers and potentially slower biological aging, though direct effects on epigenetic clocks are still under investigation [21].

Ferritin serves double duty: it screens for iron deficiency and, when elevated (above 300 ng/mL in men, above 200 ng/mL in women without acute illness), flags iron overload or chronic inflammation. Either extreme can accelerate aging processes.

Thyroid Function and Cortisol

Thyroid hormones regulate basal metabolic rate, mitochondrial function, and cellular turnover. Both overt and subclinical thyroid disease can affect biological aging trajectories.

Order TSH and free T4 at minimum. The American Thyroid Association defines the reference range for TSH as approximately 0.45 to 4.12 mIU/L, though some longevity-focused clinicians target a tighter range of 0.5 to 2.5 mIU/L [22]. Free T3 adds value in patients on thyroid hormone replacement or those with symptoms despite normal TSH.

Morning cortisol (drawn between 7:00 and 9:00 AM) screens for adrenal dysfunction. Chronic cortisol elevation, whether from endogenous Cushing syndrome or chronic psychological stress, accelerates epigenetic aging. A 2021 study of 448 Black and white Americans found that cumulative lifetime stress exposure was associated with 2.4 years of GrimAge acceleration, mediated in part by cortisol dysregulation [23].

Dr. Steve Horvath noted in a 2022 review: "The epigenetic clock does not care whether aging acceleration comes from a hormone deficiency, chronic stress, or metabolic disease. It registers the cumulative biological toll. The job of the clinician is to decompose that toll into treatable components" [1].

How to Lower Your Epigenetic Age

Interventions that reduce epigenetic age acceleration exist, and some have been tested in randomized trials. The TRIIM trial (Thymus Regeneration, Immunorestoration, and Insulin Mitigation), a small pilot study of 9 men aged 51 to 65, used recombinant human growth hormone, DHEA, and metformin for 12 months and observed a mean 2.5-year reversal of GrimAge [24]. The study was small and uncontrolled, but it demonstrated that epigenetic age is modifiable.

Lifestyle interventions show consistent effects. A randomized trial by Fitzgerald et al. (N=43 healthy males, ages 50 to 72) tested an 8-week diet and lifestyle program (plant-rich diet, exercise, sleep optimization, stress management, and supplemental probiotics) and found a 3.23-year reduction in Horvath DNAm age compared to controls (P = 0.018) [25].

Caloric restriction, exercise, and smoking cessation each independently reduce epigenetic age acceleration in observational data. Among these, smoking cessation has the largest single effect: current smoking adds approximately 4 to 5 years to GrimAge estimates, and cessation partially reverses this within 5 years [2].

Building Your Paired-Test Protocol: A Practical Order Set

The recommended panel, stratified by priority:

Tier 1 (order with every epigenetic age test):

• hsCRP
• Fasting insulin and glucose (calculate HOMA-IR)
• HbA1c
• Standard lipid panel
• CBC with differential
• TSH, free T4
• 25-hydroxyvitamin D

Tier 2 (order for comprehensive longevity assessment):

• DHEA-S
• IGF-1
• Total and free testosterone (men) or estradiol and FSH (women)
• SHBG
• Homocysteine
• Serum B12 and folate
• Ferritin

Tier 3 (order when clinical suspicion warrants):

• IL-6, TNF-alpha
• ApoB, Lp(a)
• Free T3
• Morning cortisol
• Telomere length
• Cystatin C (kidney aging marker)

Retest the epigenetic clock and Tier 1 labs every 6 to 12 months. Tier 2 and 3 markers can follow a 12-month cycle unless an intervention specifically targets one of them.

The total cost of Tier 1 labs through a standard reference laboratory runs $150 to $300 without insurance. Adding the epigenetic age panel brings the total to $350 to $800 depending on the clock selected (GrimAge, DunedinPACE, or TruDiagnostic's TruAge panel). Ordering through a telehealth platform like HealthRX can reduce out-of-pocket costs and ensure results are interpreted by a clinician familiar with biological aging metrics.

Retest at 6 months post-intervention. If your DNAm age has decreased by 1 year or more, the protocol is working. If acceleration persists, revisit the paired labs for untreated drivers.